Ownership Report for Protagenic Therapeutics, Inc.

The filing reports the ownership details of Protagenic Therapeutics, Inc. (PTIX) as of May 15, 2025. The primary reporting owners include Barrett Evans, EMC2 Capital LLC, and Mammoth Crest Capital LLC. Barrett Evans, who was the CEO and a director of PTIX, holds significant shares indirectly through EMC2 Capital LLC and Mammoth Crest Capital LLC. The filing details the ownership of various securities, including Common Stock and Preferred Stock Series C, C-1, and D. The shares are held both directly and indirectly by the reporting owners. The filing also includes a footnote clarifying that Mr. Evans was the CEO and is a director of PTIX.